These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9935313)

  • 21. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hyperlipidemias.
    Cox RA
    Bol Asoc Med P R; 2003; 95(5):36-44. PubMed ID: 15008360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid lowering strategies.
    Morrell J
    Indian Heart J; 1999; 51(5):489-93. PubMed ID: 10721637
    [No Abstract]   [Full Text] [Related]  

  • 24. Outpatient management of lipid disorders.
    La Forge R; Thomas T
    J Cardiovasc Nurs; 1996 Oct; 11(1):39-53. PubMed ID: 9069030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Which lipid parameters are atherogenic? Pathological lipid values and their therapeutic consequences].
    Thomas HP; Steinhagen-Thiessen E
    MMW Fortschr Med; 1999 Sep; 141(37):34-6. PubMed ID: 10897971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Practice guidelines--disorders of lipid metabolism. From recommendations to therapy of disorders of lipid metabolism by the Drug Committee of the German Medical Society. Drug Committee of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Jan; 94(1):61-4. PubMed ID: 10721166
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid management in patients with diabetes mellitus.
    Brown AS
    Am J Cardiol; 2005 Aug; 96(4A):26E-32E. PubMed ID: 16098840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risky high blood pressure, lipid and blood glucose values. Are blood pressure patients underserved?].
    Hense HW
    MMW Fortschr Med; 2001 Nov; 143(48):26-8. PubMed ID: 11770371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid intervention trials in diabetes.
    Steiner G
    Diabetes Care; 2000 Apr; 23 Suppl 2():B49-53. PubMed ID: 10860191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objectives of lipid clinics.
    Little A
    Adv Exp Med Biol; 1977; 82():347-8. PubMed ID: 920391
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid-lowering strategies. Today's therapies and co-therapies can reduce CHD risk.
    McDonald K
    Adv Nurse Pract; 2003 Dec; 11(12):24-8; quiz 28-9. PubMed ID: 14689742
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of exercise programs in lipid metabolism disorders].
    Apor P
    Orv Hetil; 2003 Mar; 144(11):507-13. PubMed ID: 12731337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care.
    Delaney EK; Murchie P; Lee AJ; Ritchie LD; Campbell NC
    Heart; 2008 Nov; 94(11):1419-23. PubMed ID: 18198203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ; Hunninghake DB;
    J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.